Allergy drug Singulair to get FDA warning for psychiatric effects
Thursday, March 5, 2020 - 11:00
in Health & Medicine
Asthma and allergy drug montelukast -- sold as a generic and under the brand name Singulair -- will get a "boxed warning" over potential ties to neuropsychiatric effects, the FDA announced on Wednesday.